Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient

被引：21

作者：

Piscolla, E. ^{[1
]}

Hakiki, B. ^{[1
]}

Pasto, L. ^{[1
]}

Razzolini, L. ^{[1
]}

Portaccio, E. ^{[1
]}

Amato, M. P. ^{[1
]}

机构：

[1] Univ Florence, Dept Neurol, I-50134 Florence, Italy

来源：

JOURNAL OF NEUROLOGY | 2013年 / 260卷 / 06期

关键词：

DISEASE-ACTIVITY; WITHDRAWAL;

D O I：

10.1007/s00415-013-6933-z

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1675 / 1677

页数：3

共 8 条

[1]

Awad Amer, 2009, Ther Adv Neurol Disord, V2, P50, DOI 10.1177/1756285609344375

[2]

De Vera A, 2010, MULT SCLER, V16, P295

[3] Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients [J].

Ghezzi, A. ;

Rocca, M. A. ;

Baroncini, D. ;

Annovazzi, P. ;

Zaffaroni, M. ;

Minonzio, G. ;

Comi, G. ;

Filippi, M. .

JOURNAL OF NEUROLOGY, 2013, 260 (01) :327-329

[4] Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases [J].

Hakiki, Bahia ;

Portaccio, Emilio ;

Giannini, Marta ;

Razzolini, Lorenzo ;

Pasto, Luisa ;

Amato, Maria Pia .

MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (11) :1636-1639

[5] Rebound of Disease Activity After Withdrawal of Fingolimod (FTY720) Treatment [J].

Havla, Joachim B. ;

Pellkofer, Hannah L. ;

Meinl, Ingrid ;

Gerdes, Lisa Ann ;

Hohlfeld, Reinhard ;

Kuempfel, Tania .

ARCHIVES OF NEUROLOGY, 2012, 69 (02) :262-264

[6] Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone [J].

Martinelli, V. ;

Cocco, E. ;

Capra, R. ;

Salemi, G. ;

Gallo, P. ;

Capobianco, M. ;

Pesci, I. ;

Ghezzi, A. ;

Pozzilli, C. ;

Lugaresi, A. ;

Bellantonio, P. ;

Amato, M. P. ;

Grimaldi, L. M. ;

Trojano, M. ;

Mancardi, G. L. ;

Bergamaschi, R. ;

Gasperini, C. ;

Rodegher, M. ;

Straffi, L. ;

Ponzio, M. ;

Comi, G. .

NEUROLOGY, 2011, 77 (21) :1887-1895

[7] Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis [J].

O'Connor, P. W. ;

Goodman, A. ;

Kappos, L. ;

Lublin, F. D. ;

Miller, D. H. ;

Polman, C. ;

Rudick, R. A. ;

Aschenbach, W. ;

Lucas, N. .

NEUROLOGY, 2011, 76 (22) :1858-1865

[8] Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients [J].

Vellinga, M. M. ;

Castelijns, J. A. ;

Barkhof, F. ;

Uitdehaag, B. M. J. ;

Polman, C. H. .

NEUROLOGY, 2008, 70 (13) :1150-1151

← 1 →